Author
Listed:
- Jian Liu
(National Institute of Environmental Health Sciences (NIEHS))
- Tianyuan Wang
(National Institute of Environmental Health Sciences (NIEHS))
- Chad J. Creighton
(Baylor College of Medicine (BCM)
Baylor College of Medicine (BCM)
The University of Texas MD Anderson Cancer Center)
- San-Pin Wu
(National Institute of Environmental Health Sciences (NIEHS))
- Madhumita Ray
(National Institute of Environmental Health Sciences (NIEHS))
- Kyathanahalli S. Janardhan
(Integrated Laboratory Systems)
- Cynthia J. Willson
(Integrated Laboratory Systems)
- Sung-Nam Cho
(BCM)
- Patricia D. Castro
(BCM)
- Michael M. Ittmann
(BCM)
- Jian-Liang Li
(National Institute of Environmental Health Sciences (NIEHS))
- Roger J. Davis
(University of Massachusetts Medical School
University of Massachusetts Medical School)
- Francesco J. DeMayo
(National Institute of Environmental Health Sciences (NIEHS))
Abstract
Mechanisms of lung squamous cell carcinoma (LSCC) development are poorly understood. Here, we report that JNK1/2 activities attenuate Lkb1-deficiency-driven LSCC initiation and progression through repressing ΔNp63 signaling. In vivo Lkb1 ablation alone is sufficient to induce LSCC development by reducing MKK7 levels and JNK1/2 activities, independent of the AMPKα and mTOR pathways. JNK1/2 activities is positively regulated by MKK7 during LSCC development. Pharmaceutically elevated JNK1/2 activities abates Lkb1 dependent LSCC formation while compound mutations of Jnk1/2 and Lkb1 further accelerate LSCC progression. JNK1/2 is inactivated in a substantial proportion of human LSCC and JNK1/2 activities positively correlates with survival rates of lung, cervical and head and neck squamous cell carcinoma patients. These findings not only determine a suppressive role of the stress response regulators JNK1/2 on LSCC development by acting downstream of the key LSCC suppresser Lkb1, but also demonstrate activating JNK1/2 activities as a therapeutic approach against LSCC.
Suggested Citation
Jian Liu & Tianyuan Wang & Chad J. Creighton & San-Pin Wu & Madhumita Ray & Kyathanahalli S. Janardhan & Cynthia J. Willson & Sung-Nam Cho & Patricia D. Castro & Michael M. Ittmann & Jian-Liang Li & R, 2019.
"JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression,"
Nature Communications, Nature, vol. 10(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09843-1
DOI: 10.1038/s41467-019-09843-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09843-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.